Clover Health is trading at $5.11, up +5.99%, as of 9:40 a.m. EST on November 9, 2026; no specific catalyst was reported. - Clover Health is scheduled to present at the UBS Global Healthcare Conference at 12:30 p.m. EST; the announcement does not cite it as the cause of the move. - Third-quarter results showed revenue growth, and 2026 guidance was raised, including expected full-year GAAP net income of $25 million to $35 million. - Major indexes were rising, a plausible contributor; no specific volume data was available.